These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 27217083)

  • 1. Design and stability study of an oral solution of amlodipine besylate for pediatric patients.
    van der Vossen AC; van der Velde I; Smeets OS; Postma DJ; Vermes A; Koch BC; Vulto AG; Hanff LM
    Eur J Pharm Sci; 2016 Sep; 92():220-3. PubMed ID: 27217083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physicochemical Stability of Compounded Amlodipine Besylate Suspensions in PCCA Base, SuspendIt.
    Graves RA; Mandal TK; Bostanian LA; Nguyen AT; Swopes D; Morris TC; Pramar YV
    Int J Pharm Compd; 2019; 23(6):519-527. PubMed ID: 31751949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of amlodipine besylate in two liquid dosage forms.
    Nahata MC; Morosco RS; Hipple TF
    J Am Pharm Assoc (Wash); 1999; 39(3):375-7. PubMed ID: 10363465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of chirality on the development of robust and stable tablet formulation of (S-) amlodipine besylate.
    Hadžidedić S; Uzunović A; Sehić Jazić S; Kocova El-Arini S
    Pharm Dev Technol; 2014 Dec; 19(8):930-41. PubMed ID: 24099553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new, rapid, stability-indicating UPLC method for separation and determination of impurities in amlodipine besylate, valsartan and hydrochlorothiazide in their combined tablet dosage form.
    Vojta J; Jedlička A; Coufal P; Janečková L
    J Pharm Biomed Anal; 2015 May; 109():36-44. PubMed ID: 25756663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation and Evaluation of Oral Dissolving Films of Amlodipine Besylate Using Blends of Starches With Hydroxypropyl Methyl Cellulose.
    Ayorinde JO; Odeniyi MA; Balogun-Agbaje O
    Polim Med; 2016; 46(1):45-51. PubMed ID: 28397418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinic blood pressure responses to two amlodipine salt formulations, adipate and besylate, in adult Korean patients with mild to moderate hypertension: a multicenter, randomized, double-blind, parallel-group, 8-week comparison.
    Lee HY; Kang HJ; Koo BK; Oh BH; Heung-Sun K; Kim KS; Seo HS; Ro YM; Kang JH; Woong CJ; Joo SJ; Kim MH; Joon-Han S; Yoon J; Park SH; Jin-Ok J; Ju AK; Chong-Yun R; Yeon KJ; Park KM; Lim DK; Park SY;
    Clin Ther; 2005 Jun; 27(6):728-39. PubMed ID: 16117979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioequivalence study of an extemporaneously prepared oral solution of amlodipine suitable for use in pediatric patients compared to commercial tablets.
    van der Vossen AC; van der Velde I; van den Meiracker AH; van der Nagel BC; Koch BC; Vulto AG; Hanff LM
    Int J Clin Pharmacol Ther; 2016 Jan; 54(1):65-72. PubMed ID: 26558434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulating a poorly water soluble drug into an oral solution suitable for paediatric patients; lorazepam as a model drug.
    van der Vossen AC; van der Velde I; Smeets OS; Postma DJ; Eckhardt M; Vermes A; Koch BC; Vulto AG; Hanff LM
    Eur J Pharm Sci; 2017 Mar; 100():205-210. PubMed ID: 28126558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amlodipine besylate-excipients interaction in solid dosage form.
    Abdoh A; Al-Omari MM; Badwan AA; Jaber AM
    Pharm Dev Technol; 2004; 9(1):15-24. PubMed ID: 15000463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
    Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrospun fixed dose formulations of amlodipine besylate and valsartan.
    Bukhary H; Williams GR; Orlu M
    Int J Pharm; 2018 Oct; 549(1-2):446-455. PubMed ID: 30099215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of compounded dispersing media for extemporaneous pediatric syrups with candesartan cilexetil and valsartan.
    Musko M; Sznitowska M
    Acta Pharm; 2014 Dec; 64(4):463-74. PubMed ID: 25531786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of amlodipine besylate and atenolol in multi-component tablets of mono-layer and bi-layer types.
    Aryal S; Skalko-Basnet N
    Acta Pharm; 2008 Sep; 58(3):299-308. PubMed ID: 19103566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simulated space radiation: Investigating ionizing radiation effects on the stability of amlodipine besylate API and tablets.
    Bhayani D; Naik H; Nathaniel TN; Khan S; Mehta P
    Eur J Pharm Sci; 2019 Sep; 137():104982. PubMed ID: 31276739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability study of a compounded oral solution of nicardipine for the treatment of hypertension in children.
    Fuss D; Gondé H; Lamoureux F; Pereira T; Colnot M; Buchbinder N; Coquard A; Varin R; Hervouët C
    Eur J Pharm Sci; 2021 May; 160():105738. PubMed ID: 33524504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of an extemporaneously compounded baclofen oral liquid.
    Johnson CE; Hart SM
    Am J Hosp Pharm; 1993 Nov; 50(11):2353-5. PubMed ID: 8266961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of amlodipine oral solution for the treatment of hypertension in children.
    van der Vossen AC; Cransberg K; de Winter BCM; Schreuder MF; van Rooij-Kouwenhoven RWG; Vulto AG; Hanff LM
    Int J Clin Pharm; 2020 Jun; 42(3):848-852. PubMed ID: 32378123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation and evaluation of s-(-)-amlodipine besylate and nebivolol hydrochloride tablets.
    Shaikh SA; Shaikh SS; Shahi SR; Shookur MA; Reddy LK; Padalkar AN; Thube M
    J Adv Pharm Technol Res; 2010 Apr; 1(2):199-206. PubMed ID: 22247846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of an extemporaneously compounded terbutaline sulfate oral liquid.
    Horner RK; Johnson CE
    Am J Hosp Pharm; 1991 Feb; 48(2):293-5. PubMed ID: 2003504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.